DocMorris H1 FY26 adjusted EBITDA loss narrows 62.15% to CHF 10.9 million; revenue rises 13.4% to CHF 599.2 million
Reuters2026/08/19 05:01- DocMorris H1: revenue rose 13.4% to CHF 599.2 million; net loss narrowed to CHF 53.1 million.
- Adjusted EBITDA loss narrowed to CHF 10.9 million from CHF 28.8 million; IFRS EBITDA loss widened to CHF 20 million on CHF 7.6 million one-offs.
- Germany prescription revenue jumped 38.3% to CHF 147.9 million; active Rx customers increased 15.6% year-on-year.
- Digital Services revenue climbed 71.4%; adjusted EBITDA improved on lower Rx acquisition costs and higher profit contributions from Digital Services.
- Raised 2026 outlook: external revenue growth 9%-13%; adjusted EBITDA loss CHF 10 million-CHF 17.5 million, targeting H2 EBITDA breakeven.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.

Dogecoin ETF Closure Sets October Exit for Bitwise BWOW Holders
